QUINTA-ANALYTICA s.r.o.
About QUINTA-ANALYTICA s.r.o.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Joint Stock Company "Farmak"
5
Clinical Trials at QUINTA-ANALYTICA s.r.o.
During the past decade, QUINTA-ANALYTICA s.r.o. conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Fasting Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers
2019-04-03
2019-04-17
Completed
28
Fasted Bioequivalence Study of 2 Olanzapine Film-coated Tablets, 5 mg, in Healthy, Adult Male and Female Subjects.
2020-10-21
2020-11-30
Completed
32
Fed Bioequivalence Study of 2 Metformin 500 mg Prolongued Release Tablets in 28 Healthy Male and Female Volunteers
2019-06-25
2019-07-03
Completed
28
Fasting Bioequivalence Study of 2 Metformin 500 mg Prolonged Release Tablets in 44 Healthy Male and Female Volunteers
2021-05-21
2021-05-29
Completed
44
Fed Bioequivalence Study of 2 Metformin 1000 mg Prolonged Release Tablets in 28 Healthy Male and Female Volunteers
2019-01-11
2019-01-19
Completed
28
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at QUINTA-ANALYTICA s.r.o.
According to Clinical.Site data, the most researched conditions in "QUINTA-ANALYTICA s.r.o." are
"Pharmacokinetics" (5 trials). Many other conditions were trialed in "QUINTA-ANALYTICA s.r.o." in a lesser frequency.
Clinical Trials Intervention Types at QUINTA-ANALYTICA s.r.o.
Most popular intervention types in "QUINTA-ANALYTICA s.r.o." are "Drug" (5 trials). Other intervention types were less common.
The name of intervention was led by "Glucophage® XR 500 mg prolonged release tablets (Merck Serono Ltd, UK)" (2 trials), "Metformin 1000 mg Prolonged Release Tablets (JSC Farmak, Ukraine)" (2 trials), "Glucophage® XR 1000 mg Prolonged Release Tablets" (1 trials), "Glucophage® XR 1000 mg Prolonged Release Tablets (Merck Serono Ltd, UK)" (1 trials) and "Metformin 500mg prolonged release tablets (JSC Farmak, Ukraine)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at QUINTA-ANALYTICA s.r.o.
The vast majority of trials in "QUINTA-ANALYTICA s.r.o." are
5 trials for "All" genders.
Clinical Trials Status at QUINTA-ANALYTICA s.r.o.
Currently, there are NaN active trials in "QUINTA-ANALYTICA s.r.o.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in QUINTA-ANALYTICA s.r.o.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in QUINTA-ANALYTICA s.r.o., 5 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".